Publicacións nas que colabora con Maria Melendo Viu (24)

2024

  1. Hypertrophic cardiomyopathy: New pathogenic variant in MYH7

    Medicina Clinica

2023

  1. Bleeding and embolic risk in patients with atrial fibrillation and cancer

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 344-352

  2. Heart failure in older patients with atrial fibrillation: incidence and risk factors

    Revista Espanola de Cardiologia

  3. Home exercise intervention with the Vivifrail program in frail older patients with heart failure with reduced ejection fraction. The ExFRAIL-HF randomized trial

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 939-943

  4. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

    International Journal of Cardiology, Vol. 386, pp. 59-64

  5. Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection

    Life, Vol. 13, Núm. 4

2022

  1. Acute heart failure in a kidney transplant patient

    Kidney International, Vol. 102, Núm. 1, pp. 211

  2. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention

    Revista Espanola de Cardiologia, Vol. 75, Núm. 5, pp. 375-383

  3. Incidence and Predictors of Bleeding in Patients With Cancer and Atrial Fibrillation

    American Journal of Cardiology, Vol. 167, pp. 139-146

  4. Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome

    REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211

  5. Nutrition status, obesity and outcomes in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 826-833

  6. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  7. Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342

2021

  1. Extra-adrenal paraganglioma. A cause of ventricular dysfunction?

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 141-143

  2. Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation

    International Journal of Cardiology, Vol. 327, pp. 217-222

  3. Paraganglioma extraadrenal: ¿causa de disfunción ventricular?

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 141-143

  4. Predictors of Inappropriate Dosing of Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation

    Journal of the American Medical Directors Association

  5. Renin-Angiotensin System Inhibitors Prognostic Benefit in Older Patients with Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 22, Núm. 10, pp. 2190-2195

  6. Safety of digoxin in nonagenarian patients with atrial fibrillation: lessons from the Spanish Multicenter Registry

    Journal of Geriatric Cardiology, Vol. 18, Núm. 10, pp. 809-815

2020

  1. Incidence, prognosis and predictors of heart failure after acute myocardial infarction

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14